Success Metrics

Clinical Success Rate
87.0%

Based on 20 completed trials

Completion Rate
87%(20/23)
Active Trials
2(6%)
Results Posted
30%(6 trials)
Terminated
3(8%)

Phase Distribution

Ph phase_3
2
6%
Ph not_applicable
22
61%
Ph phase_2
1
3%
Ph phase_4
3
8%

Phase Distribution

0

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution28 total trials
Phase 2Efficacy & side effects
1(3.6%)
Phase 3Large-scale testing
2(7.1%)
Phase 4Post-market surveillance
3(10.7%)
N/ANon-phased studies
22(78.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

20 of 25 finished

Non-Completion Rate

20.0%

5 ended early

Currently Active

2

trials recruiting

Total Trials

36

all time

Status Distribution
Active(5)
Completed(20)
Terminated(5)
Other(6)

Detailed Status

Completed20
unknown6
Terminated3
Not yet recruiting3
Withdrawn2
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
36
Active
2
Success Rate
87.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (3.6%)
Phase 32 (7.1%)
Phase 43 (10.7%)
N/A22 (78.6%)

Trials by Status

completed2056%
withdrawn26%
terminated38%
recruiting26%
not_yet_recruiting38%
unknown617%

Recent Activity

Clinical Trials (36)

Showing 20 of 36 trialsScroll for more
NCT03119818Not Applicable

Intracellular Phosphate Concentration Evolution During Hemodialysis by MR Spectroscopy

Completed
NCT03183245Phase 3

Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis

Completed
NCT07189741

Dynamic Breath VOC Profiling as a Non-invasive Tool to Assess Hemodialysis Adequacy

Not Yet Recruiting
NCT07054827Not Applicable

Effect of Intradialytic Resistance Versus Aerobic Exercise on Cardiovascular System in Patients on Regular Hemodialysis

Not Yet Recruiting
NCT04095039Not Applicable

HiLo: Pragmatic Trial of Higher vs Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis

Terminated
NCT02532621Not Applicable

Clinical Evaluation of a Vascular Venous Anastomotic Connector [InterGraft VIG-only Study]

Completed
NCT03350308

Prediction of Risk of Hypotension in Hemodialysis

Completed
NCT06141798Not Applicable

Twice vs Thrice Weekly Incident Hemodialysis in Elderly Patients

Recruiting
NCT06129617Not Applicable

Intermittent ADVOS vs. Hemodialysis in Non-intensive Care Patients With Liver Dysfunction

Recruiting
NCT03740048Phase 3

A Pilot Trial of Twice-weekly Versus Thrice-weekly Hemodialysis in Patients With Incident End-stage Kidney Disease

Completed
NCT03539861Not Applicable

Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease Patients

Terminated
NCT04705701Not Applicable

Comparing Post Cardiac Surgery Outcomes in ESRD Patient's With Early Dialysis Versus Standard Care

Withdrawn
NCT04527328Not Applicable

A Study to Assess the Tolerability and Efficacy of AKST1210 in Patients on Hemodialysis With Cognitive Impairment

Completed
NCT03415776Not Applicable

Twice Against Thrice-weekly Hemodialysis

Terminated
NCT03227770Not Applicable

The Benefit of Hemodialysis Plus Hemoperfusion on Mortality

Completed
NCT05429515Phase 4

Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury

Not Yet Recruiting
NCT04297345Not Applicable

Feasibility and Safety Study to Evaluate the Neuroprotective Effect of Hemodialysis in Acute Ischemic Stroke

Unknown
NCT02494843Not Applicable

Dynamic Effects of Online HDF on Cardiac Function and Myocardial Perfusion Utilising Cardiac MRI (CAMRID)

Completed
NCT02684656Not Applicable

Reduction of Oxalate and Inflammation by Hemodiafiltration vs. Hemodialysis

Completed
NCT02787161Not Applicable

Impact of HemoDiaFIltration on Physical Activity and Self- Reported Outcomes

Completed

Drug Details

Intervention Type
OTHER
Total Trials
36